サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1655463

レジオネラ菌検査の世界市場

Legionella Testing

出版日
ページ情報
英文 173 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=144.06円
レジオネラ菌検査の世界市場
出版日: 2025年02月14日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 173 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レジオネラ菌検査の世界市場は2030年までに5億5,170万米ドルに達する見込み

2024年に3億4,300万米ドルと推定されるレジオネラ菌検査の世界市場は、2024年から2030年にかけてCAGR 8.2%で成長し、2030年には5億5,170万米ドルに達すると予測されます。本レポートで分析したセグメントの1つである培養法は、CAGR 8.5%を記録し、分析期間終了時には1億2,240万米ドルに達すると予測されます。尿中抗原検査（UAT）セグメントの成長率は、分析期間中CAGR 8.6％と推定されます。

米国市場は8,840万米ドルと推定、中国はCAGR12.1％で成長予測

米国のレジオネラ菌検査市場は、2024年に8,840万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを12.1%として、2030年までに1億3,890万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ4.3%と7.3%と予測されています。欧州では、ドイツがCAGR 5.1%で成長すると予測されています。

世界のレジオネラ菌検査市場- 主要動向と促進要因のまとめ

レジオネラ菌検査が各業界で重要性を増している理由とは？

レジオネラ菌検査は、公衆衛生と水の安全性に関する世界の意識が高まるにつれて、ますます重要性を増しています。レジオネラ菌は主に水道システムに存在し、重症の肺炎の一種であるレジオネラ症を引き起こす可能性があります。病院、ホテル、公共施設のような施設では大規模な配水システムが普及しているため、レジオネラ菌の定期的な検査は、感染症の発生を防ぎ、居住者の安全を確保するために不可欠です。政府の基準や公衆衛生のガイドラインによって、健康と安全に関する規制への関心が高まっているため、特に水の安全政策が厳しい地域では、積極的なレジオネラ菌検査の必要性が高まっています。

レジオネラ菌検査市場における技術の進歩は？

技術の進歩はレジオネラ菌検査を変革し、より速く、より正確に、様々な水系で実施しやすくしました。膨大な実験時間を必要とする従来の培養法は、ポリメラーゼ連鎖反応（PCR）検査、迅速免疫測定法、酵素結合免疫吸着測定法（ELISA）検査のような高度な技術によって補完され、あるいは代替されつつあります。これらの方法は高い感度と特異性を提供し、レジオネラ菌の迅速な検出と定量を可能にします。ポータブル検査キットや自動サンプリングシステムも利用できるようになり、現場での検査が可能になりました。リアルタイムのモニタリングと早期検出機能により、これらの技術革新はレジオネラ菌検査の信頼性を高め、産業界はより厳格な水管理プロトコルを採用できるようになりました。

どの業界がレジオネラ菌検査を採用していますか？

ヘルスケア、ホスピタリティ、水管理業界は、規制遵守と公衆衛生への関心の高まりにより、レジオネラ菌検査を率先して採用しています。病院や介護施設では、弱い立場の人々を守るために頻繁にレジオネラ菌検査を使用し、ホスピタリティ業界では宿泊客の安全を守るために使用しています。さらに、産業施設、教育機関、自治体の水道システムは、環境衛生規制の遵守を維持するために、水の安全計画にレジオネラ菌検査を組み込んでいます。持続可能な水管理の実践を世界的に推進する動きは、総合的な水リスク評価の一環としてレジオネラ菌検査を取り入れることを産業界にさらに促しています。

レジオネラ菌検査市場の成長はいくつかの要因によってもたらされる

レジオネラ菌検査市場の成長は、健康意識の高まり、規制要件、検査手法の技術進歩など、いくつかの要因によって牽引されています。先進経済諸国および新興経済諸国における水質に関する規制の強化は、レジオネラ対策プログラムを優先する組織に拍車をかけています。定期的な検査を必要とするヘルスケア施設、ホテル、その他の高リスク環境の増加も主要な促進要因となっています。さらに、迅速検査とオンサイト診断ツールの革新により、レジオネラ菌検査へのアクセスが拡大し、さまざまな部門が定期検査を実施するのがより簡単で費用対効果も高くなっています。これらの要因が相まって、市場は上昇基調にあります。

セグメント

用途（臨床検査法、環境検査法）;最終用途（病院、診断ラボ、診療所、その他の最終用途）;検査タイプ（培養法、尿中抗原検査（UAT）、血清学、直接蛍光抗体検査（DFA）、核酸ベースの検出法）

調査対象企業の例（注目の41社）

  • Alere, Inc.
  • Aquacert Ltd
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company（BD）
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc.
  • Idexx Laboratories Inc.
  • Roche Diagnostics
  • Thermo Fischer Scientific, Inc.

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP16536

Global Legionella Testing Market to Reach US$551.7 Million by 2030

The global market for Legionella Testing estimated at US$343.0 Million in the year 2024, is expected to reach US$551.7 Million by 2030, growing at a CAGR of 8.2% over the analysis period 2024-2030. Culture Methods, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$122.4 Million by the end of the analysis period. Growth in the Urinary Antigen Test (UAT) segment is estimated at 8.6% CAGR over the analysis period.

The U.S. Market is Estimated at US$88.4 Million While China is Forecast to Grow at 12.1% CAGR

The Legionella Testing market in the U.S. is estimated at US$88.4 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$138.9 Million by the year 2030 trailing a CAGR of 12.1% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.3% and 7.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.1% CAGR.

Global Legionella Testing Market - Key Trends & Drivers Summarized

Why Is Legionella Testing Gaining Importance Across Industries?

Legionella testing has become increasingly important as global awareness around public health and water safety intensifies. Legionella bacteria, primarily found in water systems, can cause Legionnaires' disease, a potentially severe form of pneumonia. Given the prevalence of large-scale water distribution systems in facilities like hospitals, hotels, and public buildings, regular testing for Legionella is essential to prevent outbreaks and ensure the safety of occupants. This rising focus on health and safety regulations, driven by government standards and public health guidelines, has elevated the need for proactive Legionella testing, particularly in regions with strict water safety policies.

How Is Technology Advancing in the Legionella Testing Market?

Technological advancements have transformed Legionella testing, making it faster, more accurate, and easier to conduct across various water systems. Traditional culture methods, which require extensive lab time, are being supplemented or replaced by advanced techniques like polymerase chain reaction (PCR) testing, rapid immunoassays, and enzyme-linked immunosorbent assay (ELISA) tests. These methods offer high sensitivity and specificity, allowing for faster detection and quantification of Legionella bacteria. Portable testing kits and automated sampling systems are now available, making it feasible to conduct on-site testing. With real-time monitoring and early detection capabilities, these technological innovations have made Legionella testing more reliable, allowing industries to adopt more stringent water management protocols.

Which Industries Are Embracing Legionella Testing?

The healthcare, hospitality, and water management industries are leading adopters of Legionella testing, driven by regulatory compliance and a heightened focus on public health. Hospitals and nursing homes rely on frequent Legionella testing to protect vulnerable populations, while the hospitality sector uses it to safeguard guests. Additionally, industrial facilities, educational institutions, and municipal water systems have integrated Legionella testing into their water safety plans to maintain compliance with environmental health regulations. The global push for sustainable water management practices has further encouraged industries to incorporate Legionella testing as part of comprehensive water risk assessments.

The Growth in the Legionella Testing Market Is Driven by Several Factors

The growth in the Legionella testing market is driven by several factors, including rising health awareness, regulatory requirements, and technological advancements in testing methodologies. Increased regulations around water quality in developed and emerging economies have spurred organizations to prioritize Legionella control programs. The growing number of healthcare facilities, hotels, and other high-risk environments that require regular testing is also a key driver. Additionally, innovations in rapid testing and on-site diagnostic tools have broadened access to Legionella testing, making it easier and more cost-effective for various sectors to implement routine testing. These factors collectively underscore the market's upward trajectory.

SCOPE OF STUDY:

The report analyzes the Legionella Testing market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Application (Clinical Testing Methods, Environmental Testing Methods); End-Use (Hospitals, Diagnostic Laboratories, Clinics, Other End-Uses); Test Type (Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA), Nucleic Acid-based Detection)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 41 Featured) -

  • Alere, Inc.
  • Aquacert Ltd
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company (BD)
  • BioMerieux SA
  • Bio-Rad Laboratories, Inc.
  • Eiken Chemical Co., Ltd.
  • Hologic, Inc.
  • Idexx Laboratories Inc.
  • Roche Diagnostics
  • Thermo Fischer Scientific, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Impact of Covid-19 and a Looming Global Recession
    • Legionella Testing - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Awareness of Waterborne Diseases Driving Demand for Testing
    • Increased Demand for Legionella Testing in Healthcare Facilities
    • Growth of the Hospitality Sector Requiring Routine Water Testing
    • Technological Advancements in Rapid Detection Methods
    • Expansion of Building and Facility Maintenance Practices for Water Safety
    • Growing Focus on Routine Testing in Public and Government Buildings
    • Adoption of Automated Testing Solutions for Efficient Water Monitoring
    • Increasing Demand for Point-of-Use Legionella Testing Kits
    • Increased Awareness of Health Risks Associated with Contaminated Water
    • Growth in Industrial Applications Requiring Legionella Control
    • Surge in Smart Water Management Systems for Continuous Monitoring
    • Development of Cost-Effective Testing Solutions for Broad Adoption
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Legionella Testing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Legionella Testing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Culture Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Culture Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Culture Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Urinary Antigen Test (UAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Urinary Antigen Test (UAT) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Urinary Antigen Test (UAT) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Serology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Serology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Serology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Direct Fluorescence Antibody Test (DFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Direct Fluorescence Antibody Test (DFA) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Direct Fluorescence Antibody Test (DFA) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Nucleic Acid-based Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Nucleic Acid-based Detection by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Nucleic Acid-based Detection by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Clinical Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Clinical Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Clinical Testing Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Environmental Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Environmental Testing Methods by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Environmental Testing Methods by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Diagnostic Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Diagnostic Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 32: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 33: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: World 15-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 35: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 36: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 38: USA Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: USA Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: USA 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 41: USA Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: USA Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: USA 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 44: USA Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: USA Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: USA 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 47: Canada Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Canada Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Canada 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 50: Canada Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Canada Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Canada 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 53: Canada Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Canada Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Canada 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 56: Japan Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Japan Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Japan 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 59: Japan Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Japan Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Japan 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 62: Japan Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Japan Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Japan 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 65: China Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: China Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: China 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 68: China Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: China Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: China 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 71: China Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: China Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: China 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 74: Europe Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 75: Europe Historic Review for Legionella Testing by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Europe 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 77: Europe Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Europe Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Europe 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 80: Europe Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Europe Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Europe 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 83: Europe Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Europe Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Europe 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 86: France Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: France Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: France 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 89: France Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: France Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: France 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 92: France Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: France Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: France 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 95: Germany Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Germany Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Germany 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 98: Germany Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Germany Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Germany 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 101: Germany Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Germany Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Germany 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 104: Italy Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Italy Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Italy 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 107: Italy Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Italy Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Italy 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 110: Italy Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Italy Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Italy 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 113: UK Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: UK Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: UK 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 116: UK Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: UK Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: UK 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 119: UK Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: UK Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: UK 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 122: Spain Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Spain Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: Spain 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 125: Spain Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Spain Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: Spain 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 128: Spain Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Spain Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: Spain 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 131: Russia Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Russia Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: Russia 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 134: Russia Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Russia Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Russia 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 137: Russia Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Russia Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Russia 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 140: Rest of Europe Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Rest of Europe Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Rest of Europe 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 143: Rest of Europe Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Rest of Europe Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Rest of Europe 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 146: Rest of Europe Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Rest of Europe Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Rest of Europe 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 149: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 150: Asia-Pacific Historic Review for Legionella Testing by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Asia-Pacific 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 152: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Asia-Pacific Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Asia-Pacific 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 155: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Asia-Pacific Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Asia-Pacific 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Asia-Pacific Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Asia-Pacific 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 161: Australia Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Australia Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Australia 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 164: Australia Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Australia Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Australia 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 167: Australia Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Australia Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Australia 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 170: India Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: India Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: India 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 173: India Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: India Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: India 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 176: India Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: India Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: India 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 179: South Korea Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: South Korea Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: South Korea 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 182: South Korea Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: South Korea Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: South Korea 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 185: South Korea Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: South Korea Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: South Korea 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 188: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Rest of Asia-Pacific Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Rest of Asia-Pacific 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 191: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Rest of Asia-Pacific Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Rest of Asia-Pacific 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 194: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Asia-Pacific Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Asia-Pacific 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 197: Latin America Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 198: Latin America Historic Review for Legionella Testing by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Latin America 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 200: Latin America Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Latin America Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: Latin America 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 203: Latin America Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Latin America Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: Latin America 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 206: Latin America Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Latin America Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Latin America 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 209: Argentina Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Argentina Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Argentina 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 212: Argentina Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Argentina Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Argentina 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 215: Argentina Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Argentina Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Argentina 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 218: Brazil Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 219: Brazil Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 220: Brazil 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 221: Brazil Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 222: Brazil Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 223: Brazil 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 224: Brazil Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 225: Brazil Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 226: Brazil 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 227: Mexico Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 228: Mexico Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 229: Mexico 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 230: Mexico Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 231: Mexico Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 232: Mexico 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 233: Mexico Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 234: Mexico Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 235: Mexico 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 236: Rest of Latin America Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 237: Rest of Latin America Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 238: Rest of Latin America 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 239: Rest of Latin America Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 240: Rest of Latin America Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 241: Rest of Latin America 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 242: Rest of Latin America Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 243: Rest of Latin America Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 244: Rest of Latin America 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 245: Middle East Recent Past, Current & Future Analysis for Legionella Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 246: Middle East Historic Review for Legionella Testing by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 247: Middle East 15-Year Perspective for Legionella Testing by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 248: Middle East Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 249: Middle East Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 250: Middle East 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 251: Middle East Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 252: Middle East Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 253: Middle East 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 254: Middle East Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 255: Middle East Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 256: Middle East 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 257: Iran Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 258: Iran Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 259: Iran 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 260: Iran Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 261: Iran Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 262: Iran 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 263: Iran Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 264: Iran Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 265: Iran 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 266: Israel Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 267: Israel Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 268: Israel 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 269: Israel Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 270: Israel Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 271: Israel 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 272: Israel Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 273: Israel Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 274: Israel 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 275: Saudi Arabia Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 276: Saudi Arabia Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 277: Saudi Arabia 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 278: Saudi Arabia Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 279: Saudi Arabia Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 280: Saudi Arabia 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 281: Saudi Arabia Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 282: Saudi Arabia Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 283: Saudi Arabia 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 284: UAE Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 285: UAE Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 286: UAE 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 287: UAE Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 288: UAE Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 289: UAE 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 290: UAE Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 291: UAE Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 292: UAE 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 293: Rest of Middle East Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 294: Rest of Middle East Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 295: Rest of Middle East 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 296: Rest of Middle East Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 297: Rest of Middle East Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 298: Rest of Middle East 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 299: Rest of Middle East Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 300: Rest of Middle East Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 301: Rest of Middle East 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Legionella Testing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 302: Africa Recent Past, Current & Future Analysis for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 303: Africa Historic Review for Legionella Testing by Test Type - Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 304: Africa 15-Year Perspective for Legionella Testing by Test Type - Percentage Breakdown of Value Sales for Culture Methods, Urinary Antigen Test (UAT), Serology, Direct Fluorescence Antibody Test (DFA) and Nucleic Acid-based Detection for the Years 2015, 2025 & 2030
    • TABLE 305: Africa Recent Past, Current & Future Analysis for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 306: Africa Historic Review for Legionella Testing by Application - Clinical Testing Methods and Environmental Testing Methods Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 307: Africa 15-Year Perspective for Legionella Testing by Application - Percentage Breakdown of Value Sales for Clinical Testing Methods and Environmental Testing Methods for the Years 2015, 2025 & 2030
    • TABLE 308: Africa Recent Past, Current & Future Analysis for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 309: Africa Historic Review for Legionella Testing by End-Use - Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 310: Africa 15-Year Perspective for Legionella Testing by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Laboratories, Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION